Phase II trial of elliptinium in advanced renal cell carcinoma.
Caillé P, Mondesir JM, Droz JP, Kerbrat P, Goodman A, Ducret JP, Theodore C, Spielman M, Rouëssé J, Amiel JL.
Caillé P, et al. Among authors: rouesse j.
Cancer Treat Rep. 1985 Jul-Aug;69(7-8):901-2.
Cancer Treat Rep. 1985.
PMID: 4016798